Strategy
MSTR
Adobe
ADBE
KB Home
KBH
4
Meritage Homes
MTH
5
D.R. Horton
DHI
US Stock MarketDetailed Quotes
SERA Sera Prognostics
- 2.995
- +0.015+0.50%
Trading Apr 30 10:44 ET
112.82MMarket Cap-3.03P/E (TTM)
3.010High2.890Low28.74KVolume2.980Open2.980Pre Close84.42KTurnover0.12%Turnover RatioLossP/E (Static)37.67MShares11.05052wk High2.36P/B74.46MFloat Cap2.89052wk Low--Dividend TTM24.86MShs Float15.500Historical High--Div YieldTTM4.03%Amplitude1.100Historical Low2.937Avg Price1Lot Size
About Sera Prognostics Company
Sera Prognostics, Inc. engages in the provision of personalized diagnostics to predict and manage pregnancy complications. It focuses on developing blood tests to predict the risks of preterm birth, preeclampsia and other pregnancy complications. The company was founded by Steven W. Graves, Dennis Farrar and M. Sean Esplin in 2008 and is headquartered in Salt Lake City, UT.
Company Profile
SymbolSERA
Company NameSera Prognostics
Listing DateJul 15, 2021
Issue Price16.00
Founded2008
CEOMs. Evguenia Lindgardt
MarketNASDAQ
Employees64
Fiscal Year Ends12-31
Address2749 East Parleys Way,Suite 200
CitySalt Lake City
ProvinceUtah
CountryUnited States of America
Zip Code84109
Phone1-801-990-0520
Company Executives
- Name
- Position
- Salary
- Evguenia Lindgardt
- Director, President and Chief Executive Officer
- 693.40K
- Robert G. Harrison
- Chief Information Officer
- --
- Austin Aerts
- Chief Financial Officer and Principal Accounting Officer
- --
- Dr. Paul Kearney, PhD
- Chief Data Officer
- 847.04K
- Dr. John J. Boniface, PhD
- Chief Scientific Officer
- 431.28K
- Dr. Kim P. Kamdar, PhD
- Chairman of the Board
- 200.00K
- Sandra A.J. Lawrence
- Independent Corporate Director
- 168.48K
- Ryan Trimble
- Independent Corporate Director
- 162.50K
- Dr. Marcus Wilson, Pharm.D.
- Independent Corporate Director
- 117.58K
- Dr. Gregory C. Critchfield, M.D.,M.S.
- Director
- 139.90K
- Joshua Phillips
- Independent Director
- 169.03K
- Jeffrey T. Elliott
- Independent Director
- --
- Dr. Mansoor Raza Mirza, M.D.
- Independent Director
- 159.00K
- Dr. Jane F. Barlow, M.B.A.,M.D.,M.P.H.
- Independent Director
- 162.98K
- Benjamin G. Jackson
- General Counsel
- --
Market Insights
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
Unlock Now
Discussing
Trump 2.0 Era: How will global markets evolve?
🎙️Discussion: 1. How will tariff policies affect the movement of key assets such as U.S. stocks, gold, and Bitcoin? 2. Given this context,
Moo Live
Jan 23 16:54
MicroStrategy Q4 2024 earnings conference call